Skip to main content
CH

CONNEQT Health

CONNEQT Health provides a clinical-grade device that measures central blood pressure and arterial stiffness, offering comprehensive vascular biomarkers beyond standard readings. This enables users to proactively manage cardiovascular health by tracking trends and generating detailed reports for physician review.

Irvine, United StatesFounded 20218500+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional blood pressure monitors provide limited insight into cardiovascular health, focusing solely on brachial pressure. This approach misses critical arterial health indicators that can predict future cardiovascular events, leaving individuals unaware of underlying risks.

Solution

CONNEQT Health offers the CONNEQT Pulse, a clinical-grade device that analyzes arterial health beyond standard blood pressure readings. Leveraging SphygmoCor® technology, it measures central blood pressure, arterial stiffness, pulse pressure amplification, and heart stress. This provides users with comprehensive vascular biomarkers that are more predictive of cardiovascular risk. The device integrates with a mobile application to track trends, generate reports, and facilitate informed discussions with healthcare providers, enabling proactive cardiovascular management.

Target Audience

The primary target audience includes individuals with a family history of heart disease, those managing hypertension or metabolic health conditions, adults over 40 seeking to monitor vascular aging, and health-conscious individuals focused on longevity and performance.

Features

  • Clinical-grade arterial health monitoring device utilizing SphygmoCor® technology.
  • Measures central blood pressure (cBP), central pulse pressure (CPP), and augmentation index (AIx).
  • Assesses arterial stiffness and pulse wave velocity (PWV) to quantify vascular elasticity.
  • Calculates Subendocardial Viability Ratio (SEVR) to evaluate myocardial oxygen supply.
  • Analyzes pulse wave shape and timing to derive key vascular biomarkers.
  • Provides color-coded risk zones and trend analysis within a companion mobile application.
  • Generates detailed Cardiology Reports for physician review and informed care decisions.
  • Validated Device Listing (VDL) for clinical accuracy.
This profile is AI-generated and may contain inaccuracies.